Latest news with #RM20.7
Sinar Daily
21-07-2025
- Health
- Sinar Daily
IJN honours life-saving donors, celebrates Tun Mahathir's 100th birthday
Special recognition was given to the Health Ministry for its consistent support through UTKKKM, a partnership that continues to be critical in providing equitable access to treatment for underprivileged patients. KUALA LUMPUR - Institut Jantung Negara (IJN) paid tribute to the generous individuals and organisations who have played a vital role in saving lives by supporting treatment for underprivileged heart patients on Sunday. The appreciation ceremony also marked a significant moment in IJN's history as it celebrated the 100th birthday of its founding visionary, Tun Dr Mahathir Mohamad and the 99th birthday of Tun Dr Hasmah Mohamad Ali. Held at a hotel here, the NGO Appreciation Hi-Tea brought together representatives from 21 non-governmental organisations and key corporate donors whose continuous support has helped hundreds of patients receive critical cardiac care. Their contributions, through the IJN Foundation and direct partnerships, have made a tangible impact on the lives of many families. Among the organisations recognised were Lembaga Zakat Selangor, One Hope Charity & Welfare, Majlis Agama Islam Wilayah Persekutuan, Yayasan Tenaga Nasional, Maybank Foundation, KitaFund, Sinar Harian, Star Foundation, NSTP and others from various states and sectors. In 2024 alone, over RM49.9 million was raised through collaborative efforts involving the Government of Malaysia via Unit Taksiran Khas Kementerian Kesihatan Malaysia (UTKKKM), the IJN Foundation and 17 NGOs. These funds directly benefited 2,517 patients. As of mid-2025, a further RM20.7 million has already been channelled to support ongoing treatment for those in need. Special recognition was given to the Health Ministry for its consistent support through UTKKKM, a partnership that continues to be critical in providing equitable access to treatment for underprivileged patients. IJN Group Chief Executive Officer Professor Datuk Seri Dr Mohamed Ezani Md Taib said his team were proud to work with partners who made healing possible, not just through medical expertise, but through generosity and care. 'In 2024, the IJN Foundation funded 938 patients, amounting to RM8.4 million, covering a wide range of cardiac procedures, including congenital heart defect surgeries in children, valve replacements in elderly patients, and urgent interventional procedures in high-risk cases. 'This would not have been possible without the many generous souls who contribute year after year to the Foundation's cause. Your donations, no matter the amount, translate directly into lives saved and families kept whole,' he said in his speech. Among the organisations recognised were Lembaga Zakat Selangor, One Hope Charity & Welfare, Majlis Agama Islam Wilayah Persekutuan, Yayasan Tenaga Nasional, Maybank Foundation, KitaFund, Sinar Harian, Star Foundation, NSTP and others from various states and sectors. Dr Ezani highlighted that the very foundation of IJN was built on Tun Dr Mahathir's vision for a cardiac centre that offers both world-class expertise and equal access to care for all Malaysians. The appreciation ceremony also marked a significant moment in IJN's history as it celebrated the 100th birthday of its founding visionary, Tun Dr Mahathir Mohamad and the 99th birthday of Tun Dr Hasmah Mohamad Ali. 'It was Tun who saw the need for a national heart institute that would provide not just world-class care, but equitable access. 'An institution where the most advanced medical procedures are available, not just to the wealthy, but to all Malaysians. And today, as we see patients from every corner of the country, from every walk of life, walk through our doors and walk out healthier, we are reminded that this dream has become a living, breathing reality,' he added.
New Straits Times
18-07-2025
- Business
- New Straits Times
Ancom Nylex upbeat on Chemical T-driven growth
KUALA LUMPUR: Ancom Nylex Bhd's earnings prospects remain upbeat, supported by the upcoming commercialisation of Chemical T in the second quarter of 2025. Production is expected to scale up progressively, aiming for an annual capacity of 1,000 metric tonnes. Hong Leong Investment Bank (HLIB) also noted that the registration process for MSMA use on soybean crops in Brazil is advancing as scheduled and is likely to receive approval by mid-2025. "Its successful registration will allow the group to market MSMA products in Brazil's soybean market, allowing Ancom Nylex to tap into the tremendous addressable market that is five times larger than the sugar cane crops," it added. HLIB stated that Ancom Nylex's results were in line with consensus expectations, meeting 99.8 per cent of consensus estimates but came in slightly above its own projections, reaching 106 per cent of its estimate. This outperformance was largely attributed to stronger-than-expected margins in the industrial chemicals segment. The company reported a core net profit of RM20.7 million for the fourth quarter of financial year 2025, bringing its total earnings for the year to RM64.0 million. HLIB has maintained its 'Buy' call on the company with an unchanged target price of RM1.13. The research house said it favours Ancom Nylex because it is the sole large‑scale producer of herbicide active ingredients (AIs) in Southeast Asia, a field with very high entry barriers and sees further earnings upside from the company's pipeline of new AIs scheduled for rollout.
Malaysian Reserve
01-07-2025
- Business
- Malaysian Reserve
CC International to acquire Labuan trust company Alpadis for RM3.2m
CC International Bhd (CCIB), through its indirect wholly owned subsidiary Indah Secretarial (Penang) Sdn Bhd (ISPG), is acquiring the entire equity in Alpadis Trust (Labuan) Ltd for a total cash consideration of US$750,000 (RM3.16 million). In a Bursa Malaysia filing, the group said it had entered into a share purchase agreement with the Switzerland-based vendor, Alpadis Group Holding AG, on June 30. The acquisition will give CCIB full ownership of Alpadis, a licensed Labuan trust company involved in providing corporate and fiduciary services for asset protection, estate and tax planning, and wealth management. Alpadis was incorporated in 2011 and posted a profit after tax of US$5,661 in FY2024 on revenue of US$530,567, following a stronger FY2023 performance of US$16,759 in PAT on US$771,923 revenue. The deal, which is subject to approval from Labuan Financial Services Authority (LFSA), is expected to be completed in 4Q2025. Alpadis will become a wholly owned unit of ISPG, and indirectly of CCIB, upon completion. The deal will be funded via proceeds from CCIB's private placement exercise completed in July 2023. As at June 30, RM3.16 million of the earmarked RM20.7 million for M&A remains available for use. 'This acquisition allows CCIB to expand its regional reach and acquire Alpadis' existing client base,' the group said, adding that the deal is expected to contribute positively to the group's future earnings. Alpadis' MD Chau Ken Vui will be appointed as director post-completion. CCIB's board believes the proposed acquisition is in the best interest of the group and aligns with its strategic expansion in professional services. — TMR
